These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10922515)

  • 1. A protein kinase inhibitor, H-7, blocks naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats.
    Tokuyama S; Ho IK; Yamamoto T
    Brain Res Bull; 2000 Jul; 52(5):363-9. PubMed ID: 10922515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of diltiazem, a Ca2+ channel blocker, on naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats.
    Tokuyama S; Ho IK
    Psychopharmacology (Berl); 1996 May; 125(2):135-40. PubMed ID: 8783387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone-precipitated changes in biogenic amines and their metabolites in various brain regions of butorphanol-dependent rats.
    Tokuyama S; Wakabayashi H; Hoskins B; Ho IK
    Pharmacol Biochem Behav; 1996 Jun; 54(2):461-8. PubMed ID: 8743609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible involvement of protein kinases in physical dependence on opioids: studies using protein kinase inhibitors, H-7 and H-8.
    Tokuyama S; Feng Y; Wakabayashi H; Ho IK
    Eur J Pharmacol; 1995 Sep; 284(1-2):101-7. PubMed ID: 8549612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats.
    Tokuyama S; Zhu H; Wakabayashi H; Feng YZ; Ho IK
    J Biomed Sci; 1998; 5(1):45-53. PubMed ID: 9570513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of selective opioid receptor antagonists on morphine-induced changes in striatal and limbic dopamine metabolism.
    Piepponen TP; Ahtee L
    Pharmacol Toxicol; 1995 Sep; 77(3):204-8. PubMed ID: 8884884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of mu- and delta-opioid receptors in the effects of systemic and locally perfused morphine on extracellular levels of dopamine, DOPAC and HVA in the nucleus accumbens of the halothane-anaesthetized rat.
    Borg PJ; Taylor DA
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):582-8. PubMed ID: 9151296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the brain kappa-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol.
    Fan LW; Tien LT; Tanaka S; Ma T; Chudapongse N; Sinchaisuk S; Rockhold RW; Ho IK
    Neuroscience; 2003; 121(4):1063-74. PubMed ID: 14580956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous measurement of biogenic amines and their metabolites in rat brain regions after acute administration of and abrupt withdrawal from butorphanol or morphine.
    Wakabayashi H; Tokuyama S; Ho IK
    Neurochem Res; 1995 Oct; 20(10):1179-85. PubMed ID: 8746803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ca2+ channel blocker, diltiazem, prevents physical dependence and the enhancement of protein kinase C activity by opioid infusion in rats.
    Tokuyama S; Feng Y; Wakabayashi H; Ho IK
    Eur J Pharmacol; 1995 Jun; 279(1):93-8. PubMed ID: 7556388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain.
    Fan LW; Tanaka S; Tien LT; Ma T; Rockhold RW; Ho IK
    Brain Res Bull; 2002 Jun; 58(2):149-60. PubMed ID: 12127012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist action of the agonist/antagonist analgesic butorphanol on dopamine metabolism in the nucleus accumbens of the rat.
    Iyengar S; Kim HS; Wood PL
    Neurosci Lett; 1987 Jun; 77(2):226-30. PubMed ID: 3601233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats.
    Enrico P; Mura MA; Esposito G; Serra P; Migheli R; De Natale G; Desole MS; Miele M; Miele E
    Brain Res; 1998 Jun; 797(1):94-102. PubMed ID: 9630540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
    Sinchaisuk S; Ho IK; Rockhold RW
    Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in striatal dopamine metabolism during precipitated morphine withdrawal.
    Gramsch C; Bläsig J; Herz A
    Eur J Pharmacol; 1977 Aug; 44(3):231-40. PubMed ID: 560969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute and chronic morphine on DOPAC and glutamate at subcortical DA terminals in awake rats.
    Huang NK; Tseng CJ; Wong CS; Tung CS
    Pharmacol Biochem Behav; 1997 Mar; 56(3):363-71. PubMed ID: 9077570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release.
    Spanagel R; Almeida OF; Bartl C; Shippenberg TS
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):121-7. PubMed ID: 7862883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of opioid mu1-receptors in opioid-induced acceleration of striatal and limbic dopaminergic transmission.
    Piepponen TP; Honkanen A; Kivastik T; Zharkovsky A; Turtia A; Mikkola JA; Ahtee L
    Pharmacol Biochem Behav; 1999 Jun; 63(2):245-52. PubMed ID: 10371653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of acute nicotine on the metabolism of dopamine and the expression of Fos protein in striatal and limbic brain areas of rats during chronic nicotine infusion and its withdrawal.
    Salminen O; Seppä T; Gäddnäs H; Ahtee L
    J Neurosci; 1999 Sep; 19(18):8145-51. PubMed ID: 10479714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.